Artiva Biotherapeutics CMO sells $5,148 in stock
- Investing.com
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Artiva Biotherapeutics Inc (ARTV)
Artiva Biotherapeutics Inc stock price live, this page displays NASDAQ ARTV stock exchange data. View the ARTV premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Artiva Biotherapeutics Inc real time stock price chart below.
What Is the Artiva Biotherapeutics Inc Stock Price Today?
The Artiva Biotherapeutics Inc stock price today is 10.86.
What Is the Stock Symbol for Artiva Biotherapeutics Inc?
The stock ticker symbol for Artiva Biotherapeutics Inc is ARTV.
Is ARTV the Same as $ARTV?
$ARTV is a common way to refer to the Artiva Biotherapeutics Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Artiva Biotherapeutics Inc Trade On?
Artiva Biotherapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Artiva Biotherapeutics Inc a Good Stock to Buy?
Determining whether Artiva Biotherapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Artiva Biotherapeutics Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ARTV quote. (ISIN: US04317A1079)
What Is the Artiva Biotherapeutics Inc Stock Price Today?
The Artiva Biotherapeutics Inc stock price today is 10.86.
What Is the Stock Symbol for Artiva Biotherapeutics Inc?
The stock ticker symbol for Artiva Biotherapeutics Inc is ARTV.
Is ARTV the Same as $ARTV?
$ARTV is a common way to refer to the Artiva Biotherapeutics Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Artiva Biotherapeutics Inc Trade On?
Artiva Biotherapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Artiva Biotherapeutics Inc a Good Stock to Buy?
Determining whether Artiva Biotherapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Artiva Biotherapeutics Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ARTV quote. (ISIN: US04317A1079)
10.86
-0.28(-2.51%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
10.84
11.60
52 wk Range
2.22
14.53
ARTV is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
10.8411.60
52 wk Range
2.2214.53
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ARTV Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Strong Buy
Price Target
35.80
Upside
+229.65%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
2 analysts have revised their earnings upwards for the upcoming period
Form 4 Artiva Biotherapeutics Inc For: 28 July- Investing.com
Form DEF 14A Artiva Biotherapeutics For: 3 August- Investing.com
Form 4 Artiva Biotherapeutics Inc For: 1 August- Investing.com
- Artiva Biotherapeutics CMO sells $5,148 in stock
- Investing.com
- Form DEF 14A Artiva Biotherapeutics For: 3 August
- Investing.com
- Form 4 Artiva Biotherapeutics Inc For: 1 August
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
6 Buy
0 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 35.80
(+229.65% Upside)
Artiva Biotherapeutics Inc SWOT Analysis
Analyst Outlook | Price targets range from $20 to $23, reflecting cautious optimism amid slow enrollment and fierce competition in the evolving cell therapy landscape |
Market Positioning | Explore Artiva's strategy to penetrate community-based practices, leveraging low-cost manufacturing to potentially outmaneuver competitors in cell therapy |
Clinical Milestones | Anticipate key data readouts in Q2 2025, with analysts eyeing enrollment numbers, safety profiles, and evidence of B cell depletion in ongoing trials |
NK Cell Innovation | Artiva Biotherapeutics pioneers "CAR-T light" NK cell therapies, potentially offering improved safety and scalability for autoimmune and cancer treatments |
Earnings
Latest Release
Aug 07, 2026
EPS / Forecast
-0.63 / --
Revenue / Forecast
-- / --
Compare ARTV to Peers and Sector
Metrics to compare | ARTV | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipARTVPeersSector | |
|---|---|---|---|---|
P/E Ratio | −5.9x | −1.8x | −0.3x | |
PEG Ratio | −3.66 | −0.03 | 0.00 | |
Price / Book | 1.5x | 1.6x | 2.6x | |
Price / LTM Sales | - | 139.2x | 3.1x | |
Upside (Analyst Target) | 259.1% | 333.7% | 47.6% | |
Fair Value Upside | Unlock | 11.1% | 5.6% | Unlock |
Artiva Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing natural killer (NK) cell-based therapies for patients suffering from autoimmune diseases and cancers. Its lead product candidate includes AlloNK, an off-the-shelf NK cell therapy for patients with autoimmune diseases and cancers, such as rheumatoid arthritis, systemic lupus erythematosus, lupus nephritis, rheumatoid arthritis, pemphigus vulgaris, the anti-neutrophil cytoplasmic antibody -associated vasculitis subtypes granulomatosis with polyangiitis/microscopic polyangiitis, and B-cell-non-Hodgkin lymphoma. The company also develops AB-201, an allogeneic anti- human epidermal growth factor receptor 2 targeting chimeric antigen receptor (CAR)-NK cell product candidate for the treatment of various solid tumors, such as breast, gastric and esophageal, and bladder cancers; and AB-205, an allogeneic anti-CD5 CAR-NK cell product candidate for the treatment of hematological malignancies. Artiva Biotherapeutics, Inc. was incorporated in 2019 and is headquartered in San Diego, California.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Artiva Biotherapeutics (ARTV) Stock Price Today?
The Artiva Biotherapeutics stock price today is 10.86 USD.
What Stock Exchange Does Artiva Biotherapeutics Trade On?
Artiva Biotherapeutics is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Artiva Biotherapeutics?
The stock symbol for Artiva Biotherapeutics is "ARTV."
What Is the Artiva Biotherapeutics Market Cap?
As of today, Artiva Biotherapeutics market cap is 544.64M USD.
What Is Artiva Biotherapeutics's Earnings Per Share (TTM)?
The Artiva Biotherapeutics EPS (TTM) is -3.21.
When Is the Next Artiva Biotherapeutics Earnings Date?
Artiva Biotherapeutics will release its next earnings report on Nov 18, 2026.
From a Technical Analysis Perspective, Is ARTV a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Artiva Biotherapeutics Stock Split?
Artiva Biotherapeutics has split 0 times.
How Many Employees Does Artiva Biotherapeutics Have?
Artiva Biotherapeutics has 115 employees.
What is the current trading status of Artiva Biotherapeutics (ARTV)?
As of Aug 21, 2026, Artiva Biotherapeutics (ARTV) is trading at a price of 10.86 USD, with a previous close of 11.14 USD. The stock has fluctuated within a day range of 10.84 USD to 11.60 USD, while its 52-week range spans from 2.22 USD to 14.53 USD.
What Is Artiva Biotherapeutics (ARTV) Price Target According to Analysts?
The average 12-month price target for Artiva Biotherapeutics is 35.80 USD, with a high estimate of 41 USD and a low estimate of 23 USD. 6 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +229.65% Upside potential.
What Is the ARTV Premarket Price?
ARTV's last pre-market stock price is 11.35 USD. The pre-market share volume is 420.00, and the stock has decreased by 0.21, or 1.89%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.